Differences of hip involvement in systemic and non-systemic juvenile idiopathic arthritis

Systemic corticosteroids are continued to be administered in juvenile idiopathic arthritis (JIA) patients, especially in systemic JIA (sJIA), despite the ability of biologic therapy. One of the complications of long-term CS treatment is delayed hip arthritis development with risk of secondary hip osteoarthritis formation and total hip arthroplasty (THA).
We compared different types of hip joint lesions in JIA, especially, secondary hip osteoarthritis development and THA rates in systemic and non-systemic JIA, and evaluate systemic corticosteroids contribution to those complications.
The study included 753 JIA patients. They were divided into 2 groups: patients with sJIA and non-systemic JIA (nsJIA). Clinical and demographic characteristics, CS treatment regimens were compared.
Results. Hip arthritis was found equally often in both groups, but both secondary hip osteoarthritis (19% vs 5,3%) and THA (8.6% vs 1.6%) prevailed in the sJIA. Patients with sJIA had delayed hip involvement (57.9% vs 30.6%; p=0.019), earlier secondary hip osteoarthritis development (4.5 vs 5.1 years after the JIA onset) with younger age of secondary hip osteoarthritis achievement (13.7 vs 15.2 years; р=0.045), they also had higher inflammatory activity, greater systemic corticosteroids administration (94.8% vs 56.1%; р=0.0000001) and higher cumulative systemic corticosteroids dose (3085 mg vs 2000 mg; p=0,005). More than half patients (56.1%) with nsJIA had systemic corticosteroids treatment and impaired calcium-phosphorus metabolism.
Conclusion. Systemic corticosteroid treatment and delayed hip involvement are independent predictors of secondary hip osteoarthritis in all JIA categories. Calcium and phosphate metabolism disturbances are additional predictor for secondary hip osteoarthritis in non-systemic JIA categories

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767-778. doi: 10.1016/S0140-6736(07)60363-8

2. Singh-Grewal D, Schneider R, Bayer N, Feldman BM. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: Significance of early clinical and laboratory features. Arthritis Rheum. 2006;54(5):1595-1601. doi: 10.1002/art.21774

3. Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: Therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis. Arthritis Care Res (Hoboken). 2019;71(6):717-734. doi: 10.1002/acr.23870

4. Сорокина ЛС, Аврусин ИС, Раупов РК, Гарипова НТ, Карабахцян ММ, Хрыпов СВ, и др. Аспекты глюкокортикостероидной терапии ювенильного идиопатического артрита: Фокус на аваскулярный некроз головки бедра. Можно ли предотвратить необратимые осложнения? Лечение и профилактика. 2020;10(4):34-41. [Sorokina LS, Avrusin IS, Raupov RK, Garipova NT, Karabakhtsyan MM, Khrypov SV, et al. The aspects of glucocorticosteroid therapy of juvenile idiopathic arthritis: Focus on avascular necrosis of hip. May we prevent irreversible complications? Disease Treatment and Prevention. 2020;10(4):34-41 (In Russ.)].

5. Hyrich KL, Lal SD, Foster HE, Thornton J, Adib N, Baildam E, et al. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology (Oxford). 2010;49(1):116-122. doi: 10.1093/rheumatology/kep352

6. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al.; International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390-392.

7. Gold GE, Cicuttini F, Crema MD, Eckstein F, Guermazi A, Kijowski R, et al. OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis. Osteoarthritis Cartilage. 2015;23(5):716-731. doi: 10.1016/j.joca.2015.03.004

8. Dale K, Paus AC, Laires K. A radiographic classification system in juvenile rheumatoid arthritis applied to the knee. Eur Radiol. 1994;4:27-32. doi: 10.1007/BF00177383

9. Steinbrocker O, Traeger Ch, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140(8):659-662. doi: 10.1001/jama.1949.02900430001001

10. Spencer CH, Bernstein BH. Hip disease in juvenile rheumatoid arthritis. Curr Opin Rheumatol. 2002;14(5):536-541. doi: 10.1097/00002281-200209000-00010

11. Batthish M, Feldman BM, Babyn PS, Tyrrell PN, Schneider R. Predictors of hip disease in the systemic arthritis subtype of juvenile idiopathic arthritis. J Rheumatol. 2011;38(5):954-958. doi: 10.3899/jrheum.101146

12. Shelmerdine SC, Di Paolo PL, Tanturri de Horatio L, Malattia C, Magni-Manzoni S, Rosendahl K. Imaging of the hip in juvenile idiopathic arthritis. Pediatr Radiol. 2018;48(6):811-817. doi: 10.1007/s00247-017-4022-7

13. Isdale IC. Hip disease in juvenile rheumatoid arthritis. Ann Rheum Dis. 1970;29(6):603-608. doi: 10.1136/ard.29.6.603

14. Rostom S, Amine B, Bensabbah R, Abouqal R, HajjajHassouni N. Hip involvement in juvenile idiopathic arthritis. Clin Rheumatol. 2008;27(6):791-794. doi: 10.1007/s10067-008-0853-9

15. Harris CM, Baum J. Involvement of the hip in juvenile rheumatoid arthritis. A longitudinal study. J Bone Joint Surg Am. 1988;70(6):821-833.

16. Modesto C, Woo P, García-Consuegra J, Merino R, GarcíaGranero M, Arnal C, et al. Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol. 2001;19(2):211-217.

17. Spiegel LR, Schneider R, Lang BA, Birdi N, Silverman ED, Laxer RM, et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: A multicenter cohort study. Arthritis Rheum. 2000;43(11):2402-2409. doi: 10.1002/1529-0131(200011)43:11<2402::AIDANR5>3.0.CO;2-C

18. Barut K, Adrovic A, Sahin S, Tarcin G, Tahaoglu G, Koker O, et al. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience. Int J Rheum Dis. 2019;22(9):1661-1669. doi: 10.1111/1756-185X.13649

19. LeBlanc CM, Ma J, Taljaard M, Roth J, Scuccimarri R, Miettunen P, et al.; Canadian STeroid-Associated Osteoporosis in Pediatric Population (STOPP) Consortium. Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders. J Bone Miner Res. 2015;30(9):1667-1675. doi: 10.1002/jbmr.2511

20. Zhao FC, Li ZR, Guo KJ. Clinical analysis of osteonecrosis of the femoral head induced by steroids. Orthop Surg. 2012;4(1):28-34. doi: 10.1111/j.1757-7861.2011.00163.x

21. Kuijpers MFL, Hannink G, van Steenbergen LN, Schreurs BW. Total hip arthroplasty in young patients in the Netherlands: Trend analysis of >19,000 primary hip replacements in the Dutch Arthroplasty Register. J Arthroplasty. 2018;33(12):3704-3711. doi: 10.1016/j.arth.2018.08.020

22. Mei XY, Gong YJ, Safir O, Gross A, Kuzyk P. Long-term outcomes of total hip arthroplasty in patients younger than 55 years: A systematic review of the contemporary literature. Can J Surg. 2019;62(4):249-258. doi: 10.1503/cjs.013118

23. Bessette BJ, Fassier F, Tanzer M, Brooks CE. Total hip arthroplasty in patients younger than 21 years: A minimum, 10-year follow-up. Can J Surg. 2003;46(4):257-262.

24. Laaksonen A. A prognostic study of juvenile rheumatoid arthritis: Analysis of 544 cases. Acta Paediatr Scand. 1966;166(Suppl 1):23-30.

25. Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: A long-term follow-up study. Rheumatology (Oxford). 2000;39(2):198-204. doi: 10.1093/rheumatology/39.2.198

26. Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: Functional outcome. Rheumatology (Oxford). 2002;41(12):1428-1435. doi: 10.1093/rheumatology/41.12.1428

27. Solari N, Viola S, Pistorio A, Magni-Manzoni S, Vitale R, Ruperto N, et al. Assessing current outcomes of juvenile idiopathic arthritis: A cross-sectional study in a tertiary center sample. Arthritis Rheum. 2008;59(11):1571-1579. doi: 10.1002/art.24202. PMID: 18975357

28. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol. 2002;29(9):1989-1999.

29. Goodman SB, Hwang K, Imrie S. High complication rate in revision total hip arthroplasty in juvenile idiopathic arthritis. Clin Orthop Relat Res. 2014;472(2):637-644. doi: 10.1007/s11999-013-3326-7

30. Swarup I, Lee YY, Chiu YF, Sutherland R, Shields M, Figgie MP. Implant survival and patient-reported outcomes after total hip arthroplasty in young patients. J Arthroplasty. 2018;33(9):2893-2898. doi: 10.1016/j.arth.2018.04.016

31. Abdel MP, Figgie MP. Surgical management of the juvenile idiopathic arthritis patient with multiple joint involvement. Orthop Clin North Am. 2014;45(4):435-442. doi: 10.1016/j.ocl.2014.06.002

32. Sandiford N, Kendoff D, Muirhead-Allwood S. Osteoarthritis of the hip: Aetiology, pathophysiology and current aspects of management. Ann Joint. 2020;5:8. doi: 10.21037/aoj.2019.10.06

33. Lespasio MJ, Sultan AA, Piuzzi NS, Khlopas A, Husni ME, Muschler GF, et al. Hip osteoarthritis: A primer. Perm J. 2018;22:17-084. doi: 10.7812/TPP/17-084